Frederic Reicherz

523 total citations · 1 hit paper
13 papers, 302 citations indexed

About

Frederic Reicherz is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Frederic Reicherz has authored 13 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Infectious Diseases. Recurrent topics in Frederic Reicherz's work include Respiratory viral infections research (8 papers), Neonatal Respiratory Health Research (6 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Frederic Reicherz is often cited by papers focused on Respiratory viral infections research (8 papers), Neonatal Respiratory Health Research (6 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Frederic Reicherz collaborates with scholars based in Canada, Germany and United States. Frederic Reicherz's co-authors include Pascal M. Lavoie, Bahaa Abu-Raya, Alfonso Solimano, Joanne M. Langley, David Marchant, Abdelilah Majdoubi, Christina Michalski, David A. Goldfarb, Zenon Cieslak and Anil Chacko and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Canadian Medical Association Journal.

In The Last Decade

Frederic Reicherz

13 papers receiving 297 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Why has the epidemiology of RSV changed during the COVID-19 pandemic?

2023 111 citations Bahaa Abu-Raya, Frederic Reicherz et al. EClinicalMedicine profile →

Peers

Frederic Reicherz

EPIDE

PRM

SURGE

MICRO

Linny Kimly Phuong Australia

Pablo Obando-Pacheco Spain

Marie‐Noëlle Billard Canada

Kevin T. Shiley United States

Mauricio T. Caballero Argentina

Melissa Vermeulen Belgium

Gregg C. Sylvester United States

Marjut Haapanen Finland

Zendi Solano United States

Danielle A. Rankin United States

Linny Kimly Phuong Australia

Frederic Reicherz

167 ×0.7

EPIDE

73 ×0.6

PRM

107 ×1.0

97 ×2.6

SURGE

15 ×0.8

MICRO

Citations per year, relative to Frederic Reicherz Frederic Reicherz (= 1×) peers Linny Kimly Phuong

Countries citing papers authored by Frederic Reicherz

Since Specialization

Citations

This map shows the geographic impact of Frederic Reicherz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Reicherz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Reicherz more than expected).

Fields of papers citing papers by Frederic Reicherz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederic Reicherz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Reicherz. The network helps show where Frederic Reicherz may publish in the future.

Co-authorship network of co-authors of Frederic Reicherz

This figure shows the co-authorship network connecting the top 25 collaborators of Frederic Reicherz. A scholar is included among the top collaborators of Frederic Reicherz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederic Reicherz. Frederic Reicherz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Reicherz, Frederic, Jeffrey N. Bone, A Lavoie, et al.. (2025). Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus Infections. The Journal of Infectious Diseases. 231(5). e840–e845. 4 indexed citations

Reicherz, Frederic, Sirui Li, Allison W. Watts, et al.. (2024). Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021–2023 in Vancouver metropolitan area, British Columbia, Canada. Vaccine. 42(22). 126004–126004. 3 indexed citations

Michalski, Christina, Ju‐Hee Oh, Martin A. Prusinkiewicz, et al.. (2024). DDIT4L regulates mitochondrial and innate immune activities in early life. JCI Insight. 9(5). 2 indexed citations

Reicherz, Frederic, et al.. (2024). Efficacy of Palivizumab Immunoprophylaxis for Reducing Severe RSV Outcomes in Children with Immunodeficiencies: A Systematic Review. Journal of the Pediatric Infectious Diseases Society. 13(2). 136–143. 2 indexed citations

Abu-Raya, Bahaa, Frederic Reicherz, Christina Michalski, et al.. (2023). Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures. Journal of the Pediatric Infectious Diseases Society. 12(12). 642–645. 5 indexed citations

Abu-Raya, Bahaa, et al.. (2023). Why has the epidemiology of RSV changed during the COVID-19 pandemic?. EClinicalMedicine. 61. 102089–102089. 111 indexed citations breakdown →

Watts, Allison W., Louise C. Mâsse, David A. Goldfarb, et al.. (2023). SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada. BMJ Open. 13(6). e071228–e071228. 7 indexed citations

Abu-Raya, Bahaa, Frederic Reicherz, Jeffrey N. Bone, et al.. (2023). Respiratory syncytial virus epidemiology and clinical severity before and during the COVID-19 pandemic in British Columbia, Canada: a retrospective observational study. The Lancet Regional Health - Americas. 25. 100582–100582. 35 indexed citations

Goldfarb, David A., Louise C. Mâsse, Allison W. Watts, et al.. (2022). SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study. BMJ Open. 12(4). e057846–e057846. 15 indexed citations

10.

Reicherz, Frederic, et al.. (2022). Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures. Vaccine. 40(27). 3746–3751. 11 indexed citations

11.

Abu-Raya, Bahaa, Frederic Reicherz, & Pascal M. Lavoie. (2022). Correlates of Protection Against Respiratory Syncytial Virus Infection in Infancy. Clinical Reviews in Allergy & Immunology. 63(3). 371–380. 7 indexed citations

12.

Reicherz, Frederic, Bahaa Abu-Raya, Abdelilah Majdoubi, et al.. (2022). Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 Pandemic. The Journal of Infectious Diseases. 226(12). 2064–2068. 76 indexed citations

13.

Lavoie, Pascal M., Frederic Reicherz, Alfonso Solimano, & Joanne M. Langley. (2021). Potential resurgence of respiratory syncytial virus in Canada. Canadian Medical Association Journal. 193(29). E1140–E1141. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact